Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
Développer la qualité dans le champ sanitaire, social et médico-social
Logo
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. EMCITATE (tiratricol)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • Établissements de santé
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

EMCITATE (tiratricol)

Medicine - Posted on Sep 25 2025
Active substance (DCI)
  • tiratricol
history (2)
  • 9/10/25

    EMCITATE (tiratricol) - Peripheral thyrotoxicosis

    Summary of opinion Unfavourable opinion for reimbursement in “the treatment of peripheral thyrotoxicosis in patients with mo...
    CAV :
    54321
    icône flèche
  • 7/24/25

    EMCITATE (tiratricol) - Thyrotoxicose périphérique

    Autorisation d’accès précoce refusée à la spécialité EMCITATE (tiratricol) dans l'indication « traitement de la thyrotoxicos...
    icône flèche
Technical information
ATC code
  • H03AA04
Manufacturer
EGETIS THERAPEUTICS AB
Presentation

EMCITATE 350 microgrammes, comprimé dispersible
plaquette(s) PVC aluminium de 60 comprimé(s) (CIP : 34009 303 107 0 0)

All our publications
    Congenital, genetic and rare diseases Drug therapy Endocrine system diseases Neuromuscular diseases Paediatrics

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
b9mBeUNNdYnWND2f